Crinetics Pharmaceuticals Overview
Crinetics Pharmaceuticals Target Price
Analysts' 12-month price predictions for CRNX.
Share Price
$34.25
Average Target Price
$36.00
5.1% upside
5.1% upside1 analysts in the last 4 months
High: $36 | Low: $36
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-07-10 | Goldman SachsRichard Law | $36 | 5.1% upside |  |
| 2025-03-24 | Stifel NicolausAlex Thompson | $60 | 75.2% upside | |
| 2025-02-28 | JMP Securities | $91 | 165.7% upside | |
| 2024-08-09 | H.C. WainwrightDouglas Tsao | $69 | 101.5% upside | |
| 2024-06-04 | OppenheimerLeland Gershell | $74 | 116.1% upside | |
| 2024-05-23 | Robert W. BairdBrian Skorney | $62 | 81% upside | |
| 2024-05-22 | Morgan StanleyJeffrey Hung | $70 | 104.4% upside | |
| 2024-05-07 | Piper SandlerYasmeen Rahimi | $97 | 183.2% upside | |
| 2024-03-20 | JMP SecuritiesJonathan Wolleben | $80 | 133.6% upside | |
| 2024-03-13 | OppenheimerLeland Gershell | $54 | 57.7% upside | |
| 2023-08-31 | OppenheimerLeland Gershell | $40 | 16.8% upside | |
| 2022-05-26 | Leerink Partners | $39 | 13.9% upside | |